The Cheek Augmentation Market size was valued at USD 3.82 billion in 2022 and is projected to grow from USD 4.12 billion in 2023 to USD 7.01 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.8% during the forecast period (2023 - 2032). The growing aging population, increasing demand for cosmetic procedure, and the rising adoption of minimally invasive surgeries are driving the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
As people age, their skin loses its elasticity, which results in drooping cheeks and other signs of aging. For older patients who want to seem more youthful again, cheek augmentation is an attractive operation. In addition, the number of elderly people, or those 80 and over, is also expected to more than triple between 2015 and 2050, going from 126.5 million to 446.6 million. Moreover, by 2050, it is expected that the oldest age group would triple in a number of Asian and Latin American nations.
Furthermore, a survey done in November 2021 by WebMD LLC (US) revealed that about 75% of people over 65 are done with cosmetic surgery in the US. Therefore, in the upcoming years, the market for cheek augmentation is anticipated to be significantly influenced by the aging population.
Cosmetic surgery is performed to alter a person's look, or more simply, to enhance aesthetics. The American Society of Plastic Surgeons (ASPS) estimates that over the years, 18 million surgical cosmetic treatments were carried out in the US alone. Moreover, men are also contributing to the growth of the therapy. Additionally, around 31,000 lipoplasty (liposuction) treatments on male patients were carried out across the US in 2021. Furthermore, the top five surgical cosmetic treatments performed on males in the US in 2021 are shown in this data. year.
Figure 1: Top 5 surgical cosmetic procedures for men in the US in 2021
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The market segments of cheek augmentation, based on product, includes derma fillers, implant, and others. The dermal fillers segment is to hold the majority share in 2022 in the Cheek Augmentation Market revenue. This is due to the rising demand for minimally invasive surgeries. Dermal fillers are used by a qualified practitioner to provide a variety of outcomes, from modest improvements to more pronounced modifications. Thus, the increase in the geriatric population, surge the demand for dermal filler procedures propel the growth of the segment.
June 2021: The U.S. Food and Drug Administration (FDA) approved Galderma’s Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21.
The Cheek Augmentation Market segmentation is based on a technique, that includes, surgical and non-surgical. The non-surgical segment has dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2030. This is due to the rising interest in affordable facial rejuvenation procedures, and rising knowledge of the use of fillers in augmentation surgery. In addition, non-surgical cheek augmentation is much safer and less costly than traditional cheek implants or a surgical facelift. Moreover, the increasing number of non-surgical procedures and rising awareness about non-surgical treatments among people drove the market growth in this segment.
Figure 2: CHEEK AUGMENTATION MARKET, BY TECHNIQUE, 2022 & 2030 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Market segmentation of cheek augmentation is based on end-user that includes hospitals and clinics, ambulatory surgical centers, and specialty clinics. The hospitals and clinics segment has dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2030. This is due to the growing number of cosmetic surgeries in hospitals. Additionally, Hospitals produce significant revenue and provide a wide range of inpatient and outpatient services. Hospitals readily obtain cosmetic care products such as facial implants and maintain close relationships with a variety of suppliers, reimbursement authorities, and governmental agencies, which encourages the higher use of facial implants and benefits the worldwide market. Therefore, the rising number of inpatient visits and the increasing number of cheek augmentation surgical procedures drove the market growth in this segment.
April 2019: Merz Pharma (Germany) launched Belotero Revive, is a next-generation, injectable hyaluronic acid, skin booster designed to rejuvenate the quality of the skin and revitalise the early signs of sun damage, designed to improve hydration, elasticity, and firmness of the skin and to address the appearance of fine lines.
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North American cheek augmentation market accounted for the largest market share in 2022. This is attributed to the high technological advances, rising demand for cosmetic procedures, growing developments in healthcare infrastructure, and rising geriatric population in the region. Additionally, a robust regulatory environment in the region, which includes the US Food and Drug Administration (FDA) and Health Canada, guarantees the efficacy and safety of cosmetic operations.
Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: CHEEK AUGMENTATION MARKET BY REGION 2022 & 2030
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe cheek augmentation market is expected to account for the second-largest market share due to the increased disposable income, changing lifestyles, and the expansion of the fashion and modeling industries in the region. Further, the Germany market of cheek augmentation was attributed to holding the largest market share, and the UK market of cheek augmentation is expected to fastest-growing market in the European region.
The Asia-Pacific cheek augmentation market is expected to grow at the fastest rate from 2023 to 2030. This is due to the high untapped opportunity, rising patient awareness levels, and economic development in the region. Moreover, China’s market of cheek augmentation is expected to hold the largest market share, and India market of cheek augmentation is expected fastest-growing market in the Asia-Pacific region.
Furthermore, Additionally, it is projected that industry growth over the next seven years would be fueled by increased medical tourism activities backed by low treatment costs in two developing countries China and India, Philippines, and Thailand in the market of cheek augmentation.
The Rest of the World includes the Middle East, Africa, and Latin America. The main factors influencing the growth of cheek augmentation in the Middle East and Africa are the increase in the personal and beauty industries across the major nations, especially in Middle East. Additionally, it is projected that factors such as the region's aging population, increased disposable income, and changing lifestyles will contribute to the market's expansion. As a result, the market is rising due to the growing demand for non-invasive surgeries in the region.
Cheek Augmentation Key Market Players & Competitive Insights
The Cheek Augmentation Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as AbbVie Inc (US), Merz Pharma (Germany), GALDERMA (Switzerland), and Zimmer Biomet (US) dominate the market of cheek augmentation due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in extensive research and development as well. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.
One of the primary business strategies adopted by manufacturers in the global cheek augmentation industry to benefit clients and expand the cheek augmentation market sector is to manufacture locally to reduce operating costs
GALDERMA (Switzerland) develops products in the field of aesthetics, prescription medicines, and consumer care. It offers a wide portfolio of products used to treat different dermatological conditions. The company is present in more than 100 countries, with six manufacturing units across the world. The company works with medical professionals from all around the world to address the demands of people's skin health throughout their lifetimes. Furthermore, the company has a strong presence in North America, Latin America, Asia-Pacific, Europe, the Middle East, and Africa. For instance, in June 2021, GALDERMA (Switzerland) received U.S. Food and Drug Administration (FDA) approval for Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21. By virtue of this approval, Galderma will collaborate closely with its aesthetic injector partners to launch Restylane Contour in corresponding clinic locations across the globe.
Also, Merz Pharma (Merz) (Germany) is a global aesthetic and neurotoxin company with research & development capabilities in developing innovative products. The company aims to achieve and discover the needs of specialists and work in line with emerging needs to help patients achieve desired results. The company is directly present in more than 34 countries and offers its products in around 90 countries.
Key Companies in the Cheek Augmentation Market include
Cheek Augmentation Industry Developments
April 2021: Sinclair(UK) introduced HA filler hyaluronic acid (HA) facial filler called MaiLi. MaiLi is the new generation of dermal filler, that uses premium hyaluronic acid (HA) to deliver long-lasting, natural-looking results.
December 2021: AbbVie Inc (US) acquired Soliton, Inc.(US). The addition of Soliton and its technology complements Allergan Aesthetics' portfolio of non-invasive body contouring treatments to include a proven treatment for the appearance of cellulite.
October 2020: AbbVie Inc (US) entered into an agreement with Luminera (Israel) with a portfolio and pipeline of dermal filler products. According to the agreement, AbbVie Inc (US) will acquire Luminera's full dermal filler portfolio and R&D pipeline, enhancing Allergan Aesthetics' leading dermal filler portfolio with its JUVÉDERM collection of fillers.
January 2023: GALDERMA (Switzerland)launched of FACE by Galderma. The contemporary aesthetic visualization tool FACE by Galderma simulates the results of injectable treatments in real time using computerized face assessment. The solution also offers a comprehensive plan for customized care, empowering patients to confidently adhere to their treatment regimen.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 3.82 billion |
| Market Size 2023 | USD 4.12 billion |
| Market Size 2032 | USD 7.01 |
| Compound Annual Growth Rate (CAGR) | 7.8 % (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Technique, End-User & Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | AbbVie Inc (US), Merz Pharma (Germany), GALDERMA (Switzerland), Sientra, Inc (US), Stryker (US), Sinclair (UK), Johnson & Johnson Services, Inc (US), Anika Therapeutics, Inc (US), Hanson Medical Inc (US), and Zimmer Biomet (US). |
| Key Market Opportunities | ·        Increasing demand for cosmetic procedure ·        Rising adoption of minimally invasive surgeries |
| Key Market Dynamics | ·        The growing aging population to boost the market growth |
Cheek Augmentation Market Highlights:
Frequently Asked Questions (FAQ) :
The Cheek Augmentation Market is anticipated to reach 7.01 billion at a CAGR of 7.8% during the forecast period of 2023-2032.
The US is expected to hold a 70-80% share of the North America market for the cheek augmentation market during the forecast period of 2023-2030.
The cheek augmentation market is expected to grow at a 7.8% CAGR during the forecast period from 2023 to 2032.
The North America region market held the largest market share in the cheek augmentation market.
The key players include AbbVie Inc (US), Merz Pharma (Germany), GALDERMA (Switzerland), Sientra, Inc (US), Stryker (US), Sinclair (UK), Johnson & Johnson Services, Inc (US), Anika Therapeutics, Inc (US), Hanson Medical Inc (US), and Zimmer Biomet (US).
The non-surgical segment was estimated to lead the cheek augmentation market.
The hospitals and clinics segment are attributed to having the largest market share based on end user.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
